Science News from ESC 2017

European Society of Cardiology's ESC Congress
August 26 – 30, 2017 | Barcelona, Spain

AHA's SCIENCE NEWS covers selected late-breaking clinical trials (Hot Line trials) presented daily at ESC Congress 2017 with exclusive video interviews plus data summaries, as well as links to related simultaneous publications and important AHA resources.

Sun., Aug. 27: Hot Line 1


Cardiovascular OutcoMes for People using Anticoagulation StrategieS (COMPASS) trial: Primary Results
John William Eikelboom | McMaster University, Hamilton, Ontario, Canada



COMPASS PAD- Cardiovascular OutcoMes for People using Anticoagulation StrategieS trial: Results in Patients with Peripheral Artery Disease
Sonia Anand | McMaster Unversity, Hamilton, Ontario, Canada


CANTOS - The Canakinumab Anti-Inflammatory Thrombosis Outcomes Study
Paul M. Ridker | Brigham and Women's Hospital, Boston, MA



Catheter ablation versus standard conventional treatment in patients with left ventricular dysfunction and atrial fibrillation: the CASTLE-AF trial
Nassir Marrouch | University of Utah, Salt Lake City, UT

  • RESULTS: Ablation helps in HF with AF
     

Mon., Aug 28: Hot Lines 2 & 3


An international multicenter clustered randomized trial to IMProve treatment with oral AntiCoagulanTs in Atrial Fibrilation
Christopher B. Granger | Duke University, Durham, NC


Apixaban vs conventional therapy in anticoagulation-naive patients with atrial fibrillation undergoing cardioversion: The EMANATE Trial
Michael D. Ezekowitz | Lankenau Medical Center, Wynnewood, PA

The PRECISION-ABPM (Prospective Randomized Evaluation of Celecoxib Integrated Safety versus Ibuprofen or Naproxen Ambulatory Blood Pressure Measurement) Trial
Frank Ruschitzka | Universität Zürich, Zurich, Switzerland


A Naturally Randomized Trial Comparing the Effect of Genetic Variants that Mimic CETP Inhibitors and Statins on the Risk of Cardiovascular Disease
Brian A Ference | DMC Harper University Hospital, Detroit, MI


Airway management during cardiopulmonary resuscitation: Tracheal intubation versus bag valve mask ventilation
Frederic Adnet | Hôpital Avicenne, Bobigny, France

Tue., Aug 29: Hot Line 4


Clinical effects of anacetrapib in people with established vascular disease: Results of the Randomized EValuation of the Effects of Anacetrapib through Lipid-modification (HPS3/TIMI55-REVEAL) trial
Martin Landray | University of Oxford, Oxford, UK


Assessment of REmote HEArt Rhythm Sampling using the AliveCor heart monitor to scrEen for Atrial Fibrillation (The REHEARSE-AF study)
Julian Halcox | Swansea University Medical School, Swansea, UK